They are checking see if the reaction was from the vaccine or something else….
This happened to a British subject…
The pharmaceutical company AstraZeneca halted global trials of its coronavirus vaccine on Tuesday because of a serious and unexpected adverse reaction in a participant, the company said.
The trial’s halt, which was first reported by Stat News, will allow the British-Swedish company to conduct a safety review. How long the hold will last is unclear.
In a statement, the company described the halt as a “routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”
In large trials like the ones AstraZeneca is overseeing, the company said, participants do sometimes become sick by chance, but such illnesses “must be independently reviewed to check this carefully.”
The company said it was “working to expedite the review of the single event to minimize any potential impact on the trial timeline” and that it was “committed to the safety of our participants and the highest standards of conduct in our trials.”….
Yes this is normal in vaccine trials.
It does ,however ,point out the uncertainties that exist as to the effectiveness and safety of these various vaccines being tested.
Anyone who claims that just because someone is getting vaccinated as part of these trials that they are now in some way “protected” against the virus,as has been done here, shows their total ignorance as to what the trials are all about.
In vaccines HAVE erased polio and other diseases .,..
In NY?
Children CANNOT. go to public school without some… The routine of them start after their first year…
Tested?
They have extended our collective health and longevity….
Trump wants the rush…
Hopefully the health companies and public resist his ego and political efforts…
There have no adverse reactions to the other ca one that we know of and the one noted might not be from the vaccine…
But yea Jack.,..
This IS why they have trials…
Update…
Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin told CNN Tuesday.
“It has an excellent profile and I consider this vaccine … near perfect, and which has a near perfect profile,” Sahin said in an exclusive interview with CNN.
US drug giant Pfizer and German firm BioNTech say they plan to provide 100 million doses of their vaccine candidate, BNT162, by the end of the year, and up to 1.3 billion doses in 2021.
In July, the US Department of Health and Human Services and Department of Defense announced a $1.95 billion agreement with Pfizer to produce 100 million doses of a Covid-19 vaccine. The deal also allows the US government to acquire an additional 500 million doses….
More…